Tumor necrosis factor-α inhibitors for the treatment of pyoderma gangrenosum not associated with inflammatory bowel diseases: A multicenter retrospective study.

Detalles Bibliográficos
Publicado en:Journal of the American Academy of Dermatology Vol. 80; no. 4; pp. 1141 - 1144
Autores principales: Rousset, Laurie, de Masson, Adèle, Begon, Edouard, Villani, Axel, Battistella, Maxime, Rybojad, Michel, Jachiet, Marie, Bagot, Martine, Bouaziz, Jean-David, Lepelletier, Clémence
Formato: research Journal Article
Publicado: Elsevier B.V. Apr2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=135293562&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 135293562
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01909622
        1ZF
      jtl: Journal of the American Academy of Dermatology
      issn: 01909622
      maglogo: N
    pubinfo:
      dt: Apr2019
      vid: 80
      iid: 4
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        135293562
        135293562
        NLM30342166
        135293562
        10.1016/j.jaad.2018.10.006
        NLM30342166
        135293562
      ppf: 1141
      ppct: 3
      formats:
      tig:
        atl: Tumor necrosis factor-α inhibitors for the treatment of pyoderma gangrenosum not associated with inflammatory bowel diseases: A multicenter retrospective study.
      aug:
        au:
          Rousset, Laurie
          de Masson, Adèle
          Begon, Edouard
          Villani, Axel
          Battistella, Maxime
          Rybojad, Michel
          Jachiet, Marie
          Bagot, Martine
          Bouaziz, Jean-David
          Lepelletier, Clémence
        affil: Service de Dermatologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris, France
      sug:
        subj:
          Pyoderma Gangrenosum Drug Therapy
          Dermatologic Agents Therapeutic Use
          Female
          Tumor Necrosis Factor Antagonists and Inhibitors
          Drug Therapy, Combination
          Young Adult
          Human
          Male
          Adult
          Adrenal Cortex Hormones Therapeutic Use
          Treatment Outcomes
          Antibodies, Monoclonal Therapeutic Use
          Middle Age
          Retrospective Design
          Validation Studies
          Comparative Studies
          Evaluation Research
          Multicenter Studies
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Female
          Male
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Unknown
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N